Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

PURPOSE: The objective of this pilot trial was to evaluate the safety and efficacy of AKL1, a patented botanical formulation containing extracts of Picrorhiza kurroa, Ginkgo biloba, and Zingiber officinale, as add-on therapy for patients with chronic obstructive pulmonary disease (COPD) and chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Brockwell, Claire, Ampikaipakan, Sundari, Sexton, Darren W, Price, David, Freeman, Daryl, Thomas, Mike, Ali, Muzammil, Wilson, Andrew M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096458/
https://www.ncbi.nlm.nih.gov/pubmed/25031533
http://dx.doi.org/10.2147/COPD.S54276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096458/
https://www.ncbi.nlm.nih.gov/pubmed/25031533
http://dx.doi.org/10.2147/COPD.S54276

Ejemplares similares